We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
-17.56%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$3.14B
AUM Growth
-$780M
Cap. Flow
-$8.99M
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.84%
Holding
135
New
11
Increased
52
Reduced
41
Closed
9

Top Sells

Rank Stock Value
1
HSTM icon
HealthStream
HSTM
+$55M
2
OMCL icon
Omnicell
OMCL
+$35.9M
3
WDFC icon
WD-40
WDFC
+$31.7M
4
ROL icon
Rollins
ROL
+$30.4M
5
EGOV
NIC Inc
EGOV
+$29.7M

Sector Composition

Rank Sector Weight
1 Technology 29.05%
2 Industrials 23.16%
3 Healthcare 19.4%
4 Consumer Discretionary 8.46%
5 Materials 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BID
26
DELISTED
Sotheby's
BID
$60.3M 1.92%
1,517,855
+47,687
+3% +$1.94M
PRLB icon
27
Protolabs
PRLB
$2.1B
$58.6M 1.87%
519,751
-170,575
-25% -$21M
WAGE
28
DELISTED
WageWorks, Inc.
WAGE
$57.9M 1.85%
2,132,729
+27,988
+1% +$1.01M
AAON icon
29
Aaon
AAON
$7.5B
$57.8M 1.84%
2,473,455
-872,459
-26% -$21M
MDSO
30
DELISTED
Medidata Solutions, Inc.
MDSO
$56.6M 1.8%
839,839
-4,332
-0.5% -$306K
TYL icon
31
Tyler Technologies
TYL
$12.5B
$56M 1.78%
301,309
+108,010
+56% +$21.3M
ROG icon
32
Rogers Corp
ROG
$2.38B
$54.2M 1.73%
546,957
+16,473
+3% +$1.98M
SITE icon
33
SiteOne Landscape Supply
SITE
$4.29B
$53.8M 1.71%
972,751
+42,645
+5% +$2.67M
JBTM
34
JBT Marel
JBTM
$6.36B
$51.1M 1.63%
712,015
+206,598
+41% +$18.3M
HLIO icon
35
Helios Technologies
HLIO
$2.72B
$49.1M 1.56%
1,479,405
+59,213
+4% +$2.5M
WDFC icon
36
WD-40
WDFC
$3.1B
$46.2M 1.47%
252,177
-187,400
-43% -$31.7M
TECH icon
37
Bio-Techne
TECH
$11.2B
$46.2M 1.47%
1,277,108
+39,980
+3% +$1.67M
BL icon
38
BlackLine
BL
$1.75B
$45.5M 1.45%
1,110,837
+62,582
+6% +$2.66M
SPSC icon
39
SPS Commerce
SPSC
$2.58B
$44.2M 1.41%
1,073,164
+59,152
+6% +$2.58M
NOVT icon
40
Novanta
NOVT
$5.93B
$42.3M 1.35%
670,897
+27,380
+4% +$1.77M
CHEF icon
41
Chefs' Warehouse
CHEF
$4.5B
$41.6M 1.32%
1,299,533
-409,034
-24% -$14.2M
LMAT icon
42
LeMaitre Vascular
LMAT
$1.82B
$39.6M 1.26%
1,673,131
+66,131
+4% +$1.81M
NVEC icon
43
NVE Corp
NVEC
$621M
$38.1M 1.22%
435,776
-6,603
-1% -$598K
PCTY icon
44
Paylocity
PCTY
$8.29B
$35.1M 1.12%
+582,332
New +$37.3M
FSV icon
45
FirstService
FSV
$6.25B
$33.7M 1.07%
+491,497
New +$36.7M
NRC icon
46
NRC Health Common Stock
NRC
$428M
$23.2M 0.74%
608,093
+33,074
+6% +$1.27M
FIVN icon
47
FIVE9
FIVN
$2.18B
$21.1M 0.67%
+481,798
New +$19.4M
MTDR icon
48
Matador Resources
MTDR
$6.07B
$19.4M 0.62%
1,248,262
+58,441
+5% +$1.47M
EVI icon
49
EVI Industries
EVI
$180M
$18.4M 0.59%
551,575
+36,600
+7% +$1.37M
WHG icon
50
Westwood Holdings Group
WHG
$183M
$15.7M 0.5%
461,026
-182,103
-28% -$7.48M

Similar funds

Conestoga Capital Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Conestoga Capital Advisors held 135 positions worth $3.14B, down 20% from $3.92B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Conestoga Capital Advisors's Q4 2018 filing shows 11 new, 52 increased, 41 reduced and 9 closed positions. Its largest new stake was Paylocity: 582,332 shares worth $35.1M. The largest sale was HealthStream, an estimated $55M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.

  • Conestoga Capital Advisors's largest Q4 2018 buy was Paylocity: 582,332 shares worth $35.1M.
  • Conestoga Capital Advisors added most to Douglas Dynamics in Q4 2018, an estimated $23.5M increase.
  • Conestoga Capital Advisors's biggest Q4 2018 reduction was Omnicell, cutting an estimated $35.9M.
  • Conestoga Capital Advisors fully exited HealthStream in Q4 2018, selling an estimated $55M.
  • Conestoga Capital Advisors's ten largest holdings make up 30% of its $3.14B portfolio in Q4 2018.
  • Conestoga Capital Advisors opened 11 new positions and closed 9 in Q4 2018.
  • Conestoga Capital Advisors's portfolio value fell 20% quarter-over-quarter to $3.14B.

Based on Conestoga Capital Advisors's 13F filing for Q4 2018, filed 28 Jan 2019.